ID   SK-JHRCC-120
AC   CVCL_Z030
DR   Wikidata; Q54953675
RX   PubMed=28753786;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK-JHRCC-120.
CC   Population: Caucasian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
RX   PubMed=28753786; DOI=10.1016/j.euf.2016.08.005; PMCID=PMC5608640;
RA   Dong Y.-Y., Manley B.J., Becerra M.F., Redzematovic A., Casuscelli J.,
RA   Tennenbaum D.M., Reznik E., Han S., Benfante N.E., Chen Y.-B.,
RA   Arcila M.E., Aras O., Voss M.H., Feldman D.R., Motzer R.J., Fabbri N.,
RA   Healey J.H., Boland P.J., Chawla M., Durack J.C., Lee C.-H.,
RA   Coleman J.A., Russo P., Hakimi A.A., Cheng E.H., Hsieh J.J.-D.;
RT   "Tumor xenografts of human clear cell renal cell carcinoma but not
RT   corresponding cell lines recapitulate clinical response to sunitinib:
RT   feasibility of using biopsy samples.";
RL   Eur. Urol. Focus 3:590-598(2017).
//